Amy C. Moore is joining Summit Therapeutics as Director of Patient Engagement and Advocacy / Amy C. Moore, cancer, ivonescimab, Lung cancer, OncoDaily,

These strategies can transform your unsolicited applications from forgettable to fabulous.

Publishing highly cited papers helps postdoctoral researchers to land a faculty job.

Have you been affected by the Trump administration’s pause on communications, science meetings, and reviews? @statnews would like to hear from you.

ALT: a cat is sitting on a ping pong table looking at a blue balloon .

Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.

PIK3CA mutation is frequently concurrent with known oncogenic drivers such as EGFR mutation in lung cancer, raising an interesting question about its real function. Cachexia is a systemic disease invo...

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the

The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts, the Washington Post reported on Tuesday, citing a dozen current and former officials and sources.

The European Commission approved first-line amivantamab plus lazertinib for EGFR-mutated advanced non–small cell lung cancer.

The management of stage IV non-small cell lung cancer (NSCLC) has been transformed by recent innovations. However, access to medical innovations can be variable across sociodemographic groups in the U...

Next-generation sequencing (NGS) to detect actionable genomic driver alterations (AGAs) is critical to appropriate management of non-small cell lung c…